- Responsiveness and meaningful improvement of mobility measures following MS rehabilitation2018 | Third Faculty of Medicine
- Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes : Results from the SELECT trial2016 | First Faculty of Medicine
- Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis2017 | First Faculty of Medicine
- Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of Teriflunomide2022 | First Faculty of Medicine